FNF Fidelity National Financial (FNF) Insider Trading, Ownership & Congress Trades
Insurance · Title insurance · CIK 0001331875
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about FNF
Insiders, 180 days
-$7.2M net sold
2 sellers · 0% of sales under a 10b5-1 plan
Congress, 1 year
0 bought · 1 sold
Latest: sale, 2026-01-12
Fidelity National Financial insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Fidelity National Financial, Inc. insiders sold a net $7.2M of stock across 33 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Apr 8, 2026.
- The trade is 1213.5% of the 5,702 shares held after it.
- 1 other insider sold within 30 days.
Insider activity: EVP, Chief Legal Officer SADOWSKI PETER T sold about $3.2M of FNF on Jun 26, 2026; 1 other insider sold within 30 days.Context
- 6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Jan 5, 2026.
- The trade is 262.0% of the 3,643 shares held after it.
- 1 other insider sold within 30 days.
Insider activity: Director Dhanidina Halim sold about $4.0M of FNF on Jun 24, 2026, the largest insider sale at the company since 2024; 1 other insider sold within 30 days.Context
- 7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on Aug 19, 2024.
- No other insider sold within 30 days.
Insider activity: EVP, Chief Legal Officer SADOWSKI PETER T sold about $22.5K of FNF on Apr 8, 2026.Context
- 5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Mar 24, 2025.
- The trade is 45.5% of the 13,186 shares held after it.
- No other insider sold within 30 days.
Insider activity: Director Dhanidina Halim sold about $335.4K of FNF on Jan 5, 2026.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Jan 17, 2024.
- The trade is 2.3% of the 276,308 shares held after it.
- No other insider sold within 30 days.
Insider activity: Director LANE DANIEL D sold about $366.9K of FNF on Nov 17, 2025.33 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$7.2M over 180 days
below 63% of Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+9.1% year over year
below 52% of Insurance
Margin
28.7% net margin
more than 83% of Insurance
Buybacks
$138.0M repurchased, FY to 2026-06-30
below 51% of Insurance
Short interest
4.6% of the float short (float per yahoo 2026-10-26) · 3.6 days to cover · settled 2026-09-30
more than 75% of Insurance
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch FNF
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-24.7%12M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns FNF: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in FNF
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2026-01-12 · disclosed 30 days later
$1,001 - $15,000
Sold 2024-09-04 · disclosed 2 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
FNF planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Peter T. Sadowski
Filed 2026-06-26
$3.2M
Dhanidina Halim
Filed 2026-06-24
$74.4K
Executive pay vs shareholder return · Raymond RQuirk
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2021
$10.5M
$13.6M
$4.1M
+85%
+95%
2020
$9.7M
$8.0M
$3.8M
+34%
+23%
2019
$9.6M
$13.3M
$4.2M
+49%
+29%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $7.2M sold by insiders over 180 days. Each figure is a federal filing, dated the day it went public.
FNF financials
Revenue growth
+9.1%
XBRL, annual
Net margin
28.7%
Complaints, 90 days
7
- YoY · CFPB
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$15.4B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM FNF
| FY Dec 2025 | $14.4B |
| FY Dec 2024 | $13.7B |
| FY Dec 2023 | $11.8B |
| FY Dec 2022 | $11.6B |
| FY Dec 2021 | $15.7B |
| Jun 2026 | $4.1B |
| Mar 2026 | $3.2B |
| Dec 2025 | $4.1B |
| Sep 2025 | $4.0B |
| Jun 2025 | $3.6B |
| Mar 2025 | $2.7B |
| Dec 2024 | $3.6B |
| Sep 2024 | $3.6B |
At each fiscal year end
Single quarter
Net margin, TTM
+5.0%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM FNF
| FY Dec 2025 | +4.2% |
| FY Dec 2024 | +9.3% |
| FY Dec 2023 | +4.4% |
| FY Dec 2022 | +11.2% |
| FY Dec 2021 | +17.9% |
| Jun 2026 | +7.1% |
| Mar 2026 | +7.5% |
| Dec 2025 | -2.9% |
| Sep 2025 | +8.9% |
| Jun 2025 | +7.6% |
| Mar 2025 | +3.0% |
| Dec 2024 | +12.4% |
| Sep 2024 | +7.4% |
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM FNF
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Single quarter
Debt to equity
0.59x
long-term debt only, 2026-06-30; equity 2026-06-30
Debt to equity FNF
| FY Dec 2025 | 0.59x |
| FY Dec 2024 | 0.56x |
| FY Dec 2023 | 0.56x |
| FY Dec 2022 | 0.53x |
| FY Dec 2021 | 0.33x |
| Jun 2026 | 0.59x |
| Mar 2026 | 0.61x |
| Dec 2025 | 0.59x |
| Sep 2025 | 0.53x |
| Jun 2025 | 0.56x |
| Mar 2025 | 0.56x |
| Dec 2024 | 0.56x |
| Sep 2024 | 0.52x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
1.27x
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt FNF
| FY Dec 2025 | 1.32x |
| FY Dec 2024 | 1.58x |
| FY Dec 2023 | 1.67x |
| FY Dec 2022 | 1.34x |
| FY Dec 2021 | 1.32x |
| Jun 2026 | 1.27x |
| Mar 2026 | 1.27x |
| Dec 2025 | 1.32x |
| Sep 2025 | 1.32x |
| Jun 2025 | 1.56x |
| Mar 2025 | 1.44x |
| Dec 2024 | 1.58x |
| Sep 2024 | 1.81x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+10.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity FNF
| FY Dec 2025 | +7.9% |
| FY Dec 2024 | +17.3% |
| FY Dec 2023 | +7.9% |
| FY Dec 2022 | +16.7% |
| FY Dec 2021 | +31.5% |
| Jun 2026 | +10.1% |
| Mar 2026 | +10.1% |
| Dec 2025 | +7.9% |
| Sep 2025 | +14.2% |
| Jun 2025 | +14.2% |
| Mar 2025 | +14.7% |
| Dec 2024 | +17.3% |
| Sep 2024 | +10.5% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+0.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets FNF
| FY Dec 2025 | +0.6% |
| FY Dec 2024 | +1.4% |
| FY Dec 2023 | +0.7% |
| FY Dec 2022 | +2.0% |
| FY Dec 2021 | +5.0% |
| Jun 2026 | +0.7% |
| Mar 2026 | +0.7% |
| Dec 2025 | +0.6% |
| Sep 2025 | +1.2% |
| Jun 2025 | +1.1% |
| Mar 2025 | +1.2% |
| Dec 2024 | +1.4% |
| Sep 2024 | +0.9% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital FNF
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed FNF
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
13.87x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing FNF
| FY Dec 2025 | 24.59x |
| FY Dec 2024 | 11.64x |
| FY Dec 2023 | 25.76x |
| FY Dec 2022 | 7.78x |
| FY Dec 2021 | 4.96x |
| Jun 2026 | 16.37x |
| Mar 2026 | 16.45x |
| Dec 2025 | 24.59x |
| Sep 2025 | 13.57x |
| Jun 2025 | 13.72x |
| Mar 2025 | 15.53x |
| Dec 2024 | 11.64x |
| Sep 2024 | 21.76x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$11.5B
market value at close 2026-10-26 on 2026-07-31 shares, plus long-term debt only, 2026-06-30, minus cash 2026-06-30
Enterprise value FNF
| FY Dec 2025 | $16.6B |
| FY Dec 2024 | $15.7B |
| FY Dec 2023 | $14.5B |
| FY Dec 2022 | $10.8B |
| FY Dec 2021 | $12.5B |
| Jun 2026 | $13.5B |
| Mar 2026 | $14.5B |
| Dec 2025 | $16.6B |
| Sep 2025 | $16.8B |
| Jun 2025 | $16.0B |
| Mar 2025 | $17.2B |
| Dec 2024 | $15.7B |
| Sep 2024 | $15.6B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield FNF
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -27%, PEG needs growth
PEG, trailing FNF
| FY Dec 2025 | n/a |
| FY Dec 2024 | 0.08x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 0.05x |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | 0.24x |
| Jun 2025 | 0.78x |
| Mar 2025 | 0.47x |
| Dec 2024 | 0.08x |
| Sep 2024 | 0.81x |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $14.4B | $13.7B | $11.8B | $11.6B |
| Net income | $602.0M | $1.3B | $517.0M | $1.3B |
| EPS (diluted) | 2.21 | 4.65 | 1.91 | 4.67 |
| Operating cash flow | $5.8B | $6.8B | $6.5B | $4.4B |
| Cash | $2.6B | $3.5B | $2.8B | $2.3B |
| Long-term debt | $4.4B | $4.3B | $3.9B | $3.2B |
| Buybacks | $251.0M | $0 | $6.0M | $553.0M |
| Dividends paid | $546.0M | $532.0M | $500.0M | $489.0M |
SEC XBRL, fiscal years, as known on 2026-10-28
FNF Stock Sonar score 6/7 axes
Find similar shapesCompareFNF ranks highest on financial health (48th percentile) and growth (48th), and lowest on insider conviction (16th), among Insurance peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
FNF filings, in plain words
Are Fidelity National Financial insiders buying or selling FNF?
In the 180 days to 2026-10-28, Fidelity National Financial insiders were net sellers, a net $7.2M across purchases and sales reported on Form 4, by 2 sellers.
Have members of Congress traded FNF?
Yes. In the year to 2026-10-28, 0 House members disclosed buying FNF and 1 House member disclosed selling it; the latest on record is a sale by August Lee Pfluger dated 2026-01-12.
Read the full summary
In the 180 days to 2026-10-28, Fidelity National Financial insiders were net sellers of FNF, a net $7.2M across purchases and sales reported on Form 4 by 2 sellers. In the year to 2026-10-28, 0 members of Congress disclosed buying FNF and 1 member disclosed selling it; the latest on record is a sale by August Lee Pfluger dated 2026-01-12. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
